Add Company
Join Now

National Institute of Clinical Research Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • National Institute of Clinical Research's estimated annual revenue is currently $5M per year.(i)
  • National Institute of Clinical Research's estimated revenue per employee is $91,800

Employee Data

  • National Institute of Clinical Research has 54 Employees.(i)
  • National Institute of Clinical Research grew their employee count by 8% last year.

National Institute of Clinical Research's People

NameTitleEmail/Phone
1
OwnerReveal Email/Phone
2
VP Administrative OperationsReveal Email/Phone
3
VP, Clinical AffairsReveal Email/Phone
4
Director Medical AffairsReveal Email/Phone
5
Senior Manager, Business DevelopmentReveal Email/Phone
6
Clinical Research Site ManagerReveal Email/Phone
7
Recruitment ManagerReveal Email/Phone
8
Clinical Research ManagerReveal Email/Phone
9
Site Manager/ Lead Clinical Research CoordinatorReveal Email/Phone
10
Research AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24M21410%N/AN/A
#2
$4.8M39-19%N/AN/A
#3
$2.9M27-18%N/AN/A
#4
N/A12428%N/AN/A
#5
$22.4M22823%N/AN/A
#6
$1.7M21-5%N/AN/A
#7
$10.1M920%N/AN/A
#8
$5.8M27-53%N/AN/A
#9
$3.2M39N/AN/AN/A
#10
$5.8M54-7%N/AN/A
Add Company

What Is National Institute of Clinical Research?

The National Institute of Clinical Research (NICR) is a physician owned and managed, independent, multi-site Clinical Trial Management Organization. We are on a mission to provide state of the art medical capabilities that will guarantee NICR clients to receive the highest quality and efficiency in the clinical trial industry.

keywords:N/A

N/A

Total Funding

54

Number of Employees

$5M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.4M5413%N/A
#2
N/A5420%N/A
#3
$13.1M5454%N/A
#4
$15.3M5415%N/A
#5
$16M54-2%N/A